Personal Genome Diagnostics
In Brief This Week: Labcorp, Personal Genome Diagnostics, Applied DNA Sciences, Cytek, More
News items for the week of Feb. 21, 2022.
Labcorp to Acquire Personal Genome Diagnostics for up to $575M in Cash
The deal will add to Labcorp's cancer genomic profiling portfolio, providing kit-based options that will allow hospitals and laboratories to run tests internally.
Local Cancer Genomic Profiling Options Grow, Though Central Labs Will Likely Keep Major Role
Premium
As economic and practical challenges of next-gen sequencing have eased in recent years, more groups are bringing comprehensive cancer genomic testing in house.
Personal Genome Diagnostics, Cleveland Clinic Join Forces to Advance Liquid Biopsy
Leaders from collaborating Cleveland Clinic institutes will work with PGDx to optimize its ctDNA test reporting and adapt its technology for new oncology applications.
Tesis Labs, Personal Genome Diagnostics Ink Market Access Partnership
The companies are joining forces to develop new genomic tests for cancer patients that combine somatic and germline variant results.
Sep 23, 2019